TN Bullock, DW Mullins, TA Colella, VH Engelhard. (2001) " Manipulation of avidity to improve effectiveness of adoptively transferred CD8(+) T cells for melanoma immunotherapy in human MHC class I-transgenic mice. " J Immunol 167. 5824-31 PMID: 11698456 | Abstract and Keywords

A Kawana-Tachikawa, M Tomizawa, J Nunoya, T Shioda, A Kato, EE Nakayama, T Nakamura, Y Nagai, A Iwamoto. (2002) " An efficient and versatile mammalian viral vector system for major histocompatibility complex class I/peptide complexes. " J Virol 76. 11982-8 PMID: 12414940 | Abstract and Keywords

DM Da Silva, JT Schiller, WM Kast. (2003) " Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccines. " Vaccine 21. 3219-27 PMID: 12804851 | Abstract and Keywords

WF Cheng, CF Hung, KY Lin, M Ling, J Juang, L He, CT Lin, TC Wu. (2003) " CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination. " Gene Ther 10. 1311-20 PMID: 12883527 DOI: 10.1038/sj.gt.3301982 | Abstract and Keywords

AC Hobeika, MA Morse, T Osada, M Ghanayem, D Niedzwiecki, R Barrier, HK Lyerly, TM Clay. (2005) " Enumerating antigen-specific T-cell responses in peripheral blood: a comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysis. " J Immunother 28. 63-72 PMID: 15614046 | Abstract and Keywords

J Huang, JJ Goedert, EJ Sundberg, TD Cung, PS Burke, MP Martin, L Preiss, J Lifson, M Lichterfeld, M Carrington, XG Yu. (2009) " HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses. " J Exp Med 206. 2959-66 PMID: 20008523 DOI: 10.1084/jem.20091386 | Abstract and Keywords

L Bai, D Picard, B Anderson, V Chaudhary, A Luoma, B Jabri, EJ Adams, PB Savage, A Bendelac. (2012) " The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vδ1 TCR. " Eur J Immunol 42. 2505-10 PMID: 22829134 DOI: 10.1002/eji.201242531 | Abstract and Keywords